2. Epigenetics
  3. Epigenetic Reader Domain
  4. 2377379-55-8

2377379-55-8

Sphingosine-d<sub>9</sub> (d18:1) Chemical Structure

2377379-55-8

Chemical Structure

  • Sphingosine-d9 (d18:1)
  • Synonym(s): D-eytho-Sphigosie C18-d9
  • CAS No: 2377379-55-8
    Formula: C18H28D9NO2
    Molecular Weight: 308.55
  • IUPAC Name: (2S,3R,E)-2-aminooctadec-4-ene-15,15,16,16,17,17,18,18,18-d9-1,3-diol
  • InChIKey: WWUZIQQURGPMPG-ZVPCYXOTSA-N
  • SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO

Biological Activity: Sphingosine-d9 (d18:1) (D-eytho-Sphigosie C18-d9) is deuterium labeled Sphingosine (d18:1)[1].

Cat. No. Product Name Purity Description
HY-151232 Rilzabrutinib Rilzabrutinib (PRN1008) is an orally active Bruton's tyrosine kinase (BTK) inhibitor with anti-inflammatory and immunomodulatory activities. Rilzabrutinib can be used in the research of various inflammatory and immune-related diseases such as acute respiratory distress syndrome and sepsis.

References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]

Keywords:

Sphingosine-d9 (d18:1)